ProAssurance (NYSE:PRA - Get Free Report) released its quarterly earnings data on Tuesday. The insurance provider reported $0.25 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.25, FiscalAI reports. The company had revenue of $262.63 million during the quarter, compared to analysts' expectations of $216.86 million. ProAssurance had a net margin of 4.64% and a return on equity of 6.50%. The firm's quarterly revenue was down 3.5% on a year-over-year basis. During the same period in the previous year, the company earned $0.13 EPS.
ProAssurance Stock Up 0.0%
Shares of NYSE:PRA traded up $0.01 during trading hours on Tuesday, hitting $24.66. The company's stock had a trading volume of 700,195 shares, compared to its average volume of 916,961. ProAssurance has a 52 week low of $22.72 and a 52 week high of $24.85. The company has a debt-to-equity ratio of 0.31, a current ratio of 0.27 and a quick ratio of 0.27. The company has a market capitalization of $1.27 billion, a price-to-earnings ratio of 15.22 and a beta of 0.04. The firm's fifty day moving average price is $24.59 and its 200 day moving average price is $24.30.
Analysts Set New Price Targets
Several equities research analysts have issued reports on PRA shares. Wall Street Zen raised shares of ProAssurance from a "sell" rating to a "hold" rating in a research report on Saturday. Weiss Ratings reissued a "hold (c)" rating on shares of ProAssurance in a research report on Thursday, January 22nd. Finally, Zacks Research raised shares of ProAssurance from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, February 24th. One investment analyst has rated the stock with a Strong Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $25.00.
View Our Latest Analysis on PRA
Institutional Investors Weigh In On ProAssurance
Large investors have recently modified their holdings of the business. Russell Investments Group Ltd. raised its holdings in shares of ProAssurance by 356.2% in the 2nd quarter. Russell Investments Group Ltd. now owns 1,405 shares of the insurance provider's stock valued at $32,000 after purchasing an additional 1,097 shares in the last quarter. Tower Research Capital LLC TRC raised its holdings in shares of ProAssurance by 271.2% in the 2nd quarter. Tower Research Capital LLC TRC now owns 5,576 shares of the insurance provider's stock valued at $127,000 after purchasing an additional 4,074 shares in the last quarter. BNP Paribas Financial Markets raised its holdings in shares of ProAssurance by 22.8% in the 2nd quarter. BNP Paribas Financial Markets now owns 5,679 shares of the insurance provider's stock valued at $130,000 after purchasing an additional 1,056 shares in the last quarter. Kestra Advisory Services LLC bought a new stake in shares of ProAssurance in the 4th quarter valued at about $191,000. Finally, WINTON GROUP Ltd bought a new stake in shares of ProAssurance in the 3rd quarter valued at about $211,000. Institutional investors own 85.58% of the company's stock.
About ProAssurance
(
Get Free Report)
ProAssurance Corporation is a specialty property and casualty insurance holding company headquartered in Birmingham, Alabama. The company focuses primarily on professional liability coverage for healthcare providers, including physicians, surgeons, dentists and allied health professionals. ProAssurance operates through a group of insurance subsidiaries that underwrite both occurrence- and claims-made policies tailored to the unique risks faced by the medical community.
In addition to professional liability insurance, ProAssurance offers a suite of complementary property and casualty products, such as general liability, workers' compensation, property and inland marine, and umbrella coverage.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider ProAssurance, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ProAssurance wasn't on the list.
While ProAssurance currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.